ArticleBioinformation2025
Dry needling versus platelet-rich plasma in myofascial pain: A randomized trial.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Platelet-Rich Plasma Versus Polydeoxyribonucleotide for Myofascial Pain Syndrome and Musculoskeletal Disorders: A Narrative Review of Mechanisms, Clinical Evidence, and Translational Considerations.Bioengineering (Basel, Switzerland) · 2026Review
- Myofascial trigger points as a primary cause of equine lameness: a biomechanical, neurophysiological, and fascial review.Frontiers in veterinary science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The efficacy of dry needling (DN) and platelet-rich plasma (PRP) in managing trigger points in Myofascial Pain Dysfunction Syndrome (MPDS). Hence, Twenty-two patients were equally divided into DN and PRP groups and evaluated using the Pain Disability Questionnaire (PDQ), Numerical Rating Scale (NRS), maximum mouth opening (MMO) and tenderness at baseline, post-treatment, 4 weeks and 12 weeks. Both groups showed significant improvement in pain and function, but PRP demonstrated superior effectiveness in reducing pain and enhancing jaw mobility at follow-ups. Thus, we show that PRP may be a more effective long-term treatment for MPDS compared to dry needling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.